Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (1-10 of 437) with videos related to

Pageof 44
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycinHelio S Sader, Ronald N Jones
Expert Review of Anti-Infective Therapy|February 3, 2007
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infectionsHelio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|April 26, 2005
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter sppHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 15, 2009
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008)Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|January 25, 2005
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilliHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 22, 2012
Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative StaphylococcusHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|June 13, 2006
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?Ronald N Jones, Helio S Sader
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 26, 2003
The use of molecular typing to evaluate the dissemination of antimicrobial resistance among Gram-negative rods in Brazilian hospitalsIraci Tosin, Suzane Silbert, Helio S Sader
Journal of Chemotherapy (Florence, Italy)|September 28, 2013
Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and IsraelMariana Castanheira, Ronald N Jones, Helio S Sader
Microbial Drug Resistance (Larchmont, N.Y.)|February 27, 2023
Re: "Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States" by Karlsson et alHelio S Sader, Rodrigo E Mendes, Mariana Castanheira
Pageof 44

Showing results (1-10 of 437) with videos related to

Sort By:
Pageof 44
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycinHelio S Sader, Ronald N Jones
Expert Review of Anti-Infective Therapy|February 3, 2007
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infectionsHelio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|April 26, 2005
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter sppHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 15, 2009
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008)Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|January 25, 2005
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilliHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 22, 2012
Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative StaphylococcusHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|June 13, 2006
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?Ronald N Jones, Helio S Sader
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 26, 2003
The use of molecular typing to evaluate the dissemination of antimicrobial resistance among Gram-negative rods in Brazilian hospitalsIraci Tosin, Suzane Silbert, Helio S Sader
Journal of Chemotherapy (Florence, Italy)|September 28, 2013
Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and IsraelMariana Castanheira, Ronald N Jones, Helio S Sader
Microbial Drug Resistance (Larchmont, N.Y.)|February 27, 2023
Re: "Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States" by Karlsson et alHelio S Sader, Rodrigo E Mendes, Mariana Castanheira
Pageof 44